Wexford Capital »

Cara Therapeutics shares owned by Wexford Capital

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Wexford Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 17k 0.74
2015-06-30 $608k 50k 12.16

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
International Seaways (INSW)
Nephros (NEPH)
Ishares Msci Aust Etf (EWA)
Ishares Msci Cda Etf (EWC)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Cenovus Energy (CVE)
Stellantis SHS (STLA)
Cool Common Shares (CLCO)
Astrazeneca Sponsored Adr (AZN)
Silverbow Resources (SBOW)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Golar Lng SHS (GLNG)
Enterprise Products Partners (EPD)

View all positions for Wexford Capital

Top funds holding Cara Therapeutics

Vanguard Group
Chescapmanager
Rosalind Advisors
Federated Investors
AQR Capital Management
Jacobs Levy Equity Management
Bank of America Corporation
Two Sigma Advisers
Millennium Management
Stifel Financial
Two Sigma Investments
Bnp Paribas Arbitrage, Snc
Charles Schwab Investment Management
GSA Capital Partners
Goldman Sachs Group

View all funds holding Cara Therapeutics